Omani Scholar Creates Cancer Therapy Employing Genetically Altered Bacteria.

As reported by the Oman Observer, the creative project secured first place in a national contest and the privilege of representing the Sultanate of Oman at the esteemed Falling Walls International Forum in Berlin, Germany, this November.

The initiative employs genetically modified bacteria as an intelligent therapeutic approach aimed at directly addressing tumor environments. These bacteria are designed to either release anti-cancer substances or activate the immune system to target cancer cells directly at the tumor location.

Al Qaidiyah stated that the initiative seeks to provide an alternative to conventional cancer therapies, drastically minimizing the detrimental side effects of chemotherapy and paving the way for advancements in personalized medicine.

A primary benefit of this method is the capability of the bacteria to specifically target cancer cells, which protects healthy tissues and enhances the likelihood of tumor management or reduction. This approach shows potential for addressing advanced-stage cancers that have not reacted to standard treatments.

“What sets this project apart is its use of intelligent microorganisms as a therapeutic method, unlike the majority of studies that concentrate on chemotherapy or radiation,” she stated. “It integrates biotherapy with genetic modification, creating opportunities for customized therapies designed for the unique tumor type of each patient.”

Looking forward, Al Qaidiyah set forth ambitious future objectives for the project, such as creating a bacterial-based prototype for clinical testing, partnering with global research institutions and universities to confirm the treatment’s effectiveness and safety, and broadening the study to encompass various cancer types. Her goal is to secure a patent for the innovation as a significant Omani contribution to the worldwide battle against cancer.